Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kit C B Roes

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
British Journal of Clinical Pharmacology|January 9, 2026
Intravenous lanadelumab for the treatment of moderately ill COVID-19 patientsJob J Engel, Christine van Linge, W Joost Wiersinga, et al.
Orphanet Journal of Rare Diseases|November 14, 2018
Applicability and added value of novel methods to improve drug development in rare diseasesMarian Mitroiu, Katrien Oude Rengerink, Caridad Pontes, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 10, 2020
TRICALS: creating a highway toward a cureRuben P A van Eijk, Tessa Kliest, Christopher J McDermott, et al.
Molecular Genetics and Metabolism|March 14, 2025
SIMPATHIC: Accelerating drug repurposing for rare diseases by exploiting SIMilarities in clinical and molecular PATHologyClara D M van Karnebeek, Annelieke R Müller, Laura Benkemoun, et al.
Journal of Medical Internet Research|September 22, 2021
A Road Map for Remote Digital Health Technology for Motor Neuron DiseaseRuben P A van Eijk, Anita Beelen, Esther T Kruitwagen, et al.
Neurology|July 28, 2021
Innovating Clinical Trials for Amyotrophic Lateral Sclerosis: Challenging the Established OrderRuben P A van Eijk, Stavros Nikolakopoulos, Kit C B Roes, et al.
Pharmacoepidemiology and Drug Safety|April 3, 2016
Case-only designs for studying the association of antidepressants and hip or femur fractureMark C H de Groot, Gianmario Candore, Md Jamal Uddin, et al.
Clinical Pharmacology and Therapeutics|June 3, 2025
Optimizing Patient Registries for Regulatory Decision Making - Key Learnings From an HMA/EMA Multistakeholder WorkshopKelly Plueschke, Carla Jonker, Hanna Kankanen, et al.
Brain Communications|January 12, 2023
Randomized double-blind placebo-controlled crossover trial with pyridostigmine in spinal muscular atrophy types 2-4Marloes Stam, Camiel A Wijngaarde, Bart Bartels, et al.
Trials|December 5, 2022
Lithium carbonate in amyotrophic lateral sclerosis patients homozygous for the C-allele at SNP rs12608932 in UNC13A: protocol for a confirmatory, randomized, group-sequential, event-driven, double-blind, placebo-controlled trialSean W Willemse, Kit C B Roes, Philip Van Damme, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
British Journal of Clinical Pharmacology|January 9, 2026
Intravenous lanadelumab for the treatment of moderately ill COVID-19 patientsJob J Engel, Christine van Linge, W Joost Wiersinga, et al.
Orphanet Journal of Rare Diseases|November 14, 2018
Applicability and added value of novel methods to improve drug development in rare diseasesMarian Mitroiu, Katrien Oude Rengerink, Caridad Pontes, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 10, 2020
TRICALS: creating a highway toward a cureRuben P A van Eijk, Tessa Kliest, Christopher J McDermott, et al.
Molecular Genetics and Metabolism|March 14, 2025
SIMPATHIC: Accelerating drug repurposing for rare diseases by exploiting SIMilarities in clinical and molecular PATHologyClara D M van Karnebeek, Annelieke R Müller, Laura Benkemoun, et al.
Journal of Medical Internet Research|September 22, 2021
A Road Map for Remote Digital Health Technology for Motor Neuron DiseaseRuben P A van Eijk, Anita Beelen, Esther T Kruitwagen, et al.
Neurology|July 28, 2021
Innovating Clinical Trials for Amyotrophic Lateral Sclerosis: Challenging the Established OrderRuben P A van Eijk, Stavros Nikolakopoulos, Kit C B Roes, et al.
Pharmacoepidemiology and Drug Safety|April 3, 2016
Case-only designs for studying the association of antidepressants and hip or femur fractureMark C H de Groot, Gianmario Candore, Md Jamal Uddin, et al.
Clinical Pharmacology and Therapeutics|June 3, 2025
Optimizing Patient Registries for Regulatory Decision Making - Key Learnings From an HMA/EMA Multistakeholder WorkshopKelly Plueschke, Carla Jonker, Hanna Kankanen, et al.
Brain Communications|January 12, 2023
Randomized double-blind placebo-controlled crossover trial with pyridostigmine in spinal muscular atrophy types 2-4Marloes Stam, Camiel A Wijngaarde, Bart Bartels, et al.
Trials|December 5, 2022
Lithium carbonate in amyotrophic lateral sclerosis patients homozygous for the C-allele at SNP rs12608932 in UNC13A: protocol for a confirmatory, randomized, group-sequential, event-driven, double-blind, placebo-controlled trialSean W Willemse, Kit C B Roes, Philip Van Damme, et al.
Pageof 11